{"Clinical Trial ID": "NCT00591864", "Intervention": ["INTERVENTION 1:", "Participants in the study", "There are no arms or subgroups in this study."], "Eligibility": ["Incorporation criteria:", "This study will include a population of women aged 25 years and older who require a breast MRI examination at MAYO CLINIC ROCHESTER.", "Patients should not be breast-feeding or pregnant.", "All women of childbearing potential should have had a negative pregnancy test within 2 days of the MBI study.", "Women who are scheduled for a breast MRI examination for clinical concern, problem solving or further assessment of invasive breast cancer (e.g., pre-operative establishment of known breast cancer).", "- Exclusion criteria:", "They are unable to understand and sign the consent form", "They are pregnant or breastfeeding.", "They are physically unable to sit upright and still for 40 minutes.", "The mammary MRI is used for screening purposes or to determine the state of breast augmentation.", "They had breast surgery in the previous year."], "Results": ["Performance measures:", "\u2022 Sensitivity at patient level", "Sensitivity is the number of women with breast cancer detected by many women with breast cancer diagnosed by surgery or biopsy.", "Time: within 1 week of surgery or biopsy", "Results 1:", "Title of the arm/group: Participants in the study", "Description of the arm/group: There are no arms or subgroups in this study.", "Total number of participants analysed: 28", "Type of measurement: Number", "Unit of measure: participants MBI sensitivity: 25", "- Sensitivity by MRI: 27"], "Adverse Events": ["Undesirable Events 1:", "Total: 0/89 (0.00 per cent)"]}